The Recall Desk
HighFDA (Devices)·Z-0886-2026·Announced 2025-12-17

[pending] MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C

Pending LLM rewrite. Source: FDA_DEVICE Z-0886-2026.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing BD Luer Tip Caps. BD has issued a recall of their Luer Tip Caps after confirming through internal testing that certain BD Luer Tip Cap trays failed routine biocompatibility testing. Although the tip cap covers a small surface area of the syringe and does not come in direct contact with patients, there is the potential that the failure of a biocompatibility test may have varying consequences ranging from no harm or clinical impact to potential for sensitization, irritation, pyrogenicity, acute systemic toxicity or hemolysis depending on the nature and duration of contact with the syringe.

The recalled product

Product
MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C
Manufacturer
Medline Industries, LP

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • UDI/DI 10193489621532 (each) 40193489621533 (case)
  • Lot Number 25FMJ081

Distribution

Distributed nationwide across the United States.